Low-level doxorubicin resistance in P-glycoprotein-negative human pancreatic tumour PSN1/ADR cells implicates a brefeldin A-sensitive mechanism of drug extrusion.

The human pancreatic tumour cell line PSN1/ADR, stepwise selected in 17-510 nM doxorubicin, displayed a multidrug resistance not conferred by P-glycoprotein (P-gp). Resistance to 17-51 nM doxorubicin was accompanied by overexpression of the vesicular marker lung resistance-related protein (LRP). Fur...

Descripción completa

Detalles Bibliográficos
Autores principales: Verovski, V. N., Van den Berge, D. L., Delvaeye, M. M., Scheper, R. J., De Neve, W. J., Storme, G. A.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1996
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074337/
https://www.ncbi.nlm.nih.gov/pubmed/8605092

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074337/
https://www.ncbi.nlm.nih.gov/pubmed/8605092

Ejemplares similares